Sikiric's lab in Croatia) No independent replication No competing research Raises red flags about bias Human data: ONE small retrospective study (not a randomized trial) No large-scale clinical trials No safety studies Unknown dosing Unknown side effects Recent systematic review (2024): Published in orthopaedic literature, concluded: "BPC-157 has potential based on preclinical data, but there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without publication." Reported Side Effects (From Online Users): Anonymous reports include: Injection site pain and swelling Joint pain Anxiety and panic attacks Heart palpitations Insomnia or drowsiness Fatigue and weakness Loss of appetite Depression and anhedonia (inability to feel pleasure) Note: These are anecdotal, not from clinical trials
Hims dropped its plan to sell Wegovy copycats the next day
Rather than purchasing from unknown sources with limited information, researchers can choose Dynamic Peptides for trusted products, fast shipping, and responsive support
Insofar as other cookies (e.g
10.1152/ajpgi.00562.2006 126 WillardF
GLP-1s are intended to be utilized alongside healthy lifestyle changes, and without them can leave an individual vulnerable to reverting once they cease GLP-1 treatment (e.g., after one to two years due to side effects)
